Mutations in Brca1 BRCT Domains

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
<scene name='75/752201/Cv/4'>Brca1 BRCT domains in complex with the phosphorylated interacting region from Bach1 Helicase</scene>.
<scene name='75/752201/Cv/4'>Brca1 BRCT domains in complex with the phosphorylated interacting region from Bach1 Helicase</scene>.
-
<scene name='75/752201/Cv/2'>Pathogenic and benign mutations in BRCT domain</scene>. <font color='magenta'><b>Pathogenic mutations are shown in magenta</b></font>, <font color='lime'><b>benign mutations are shown in green</b></font>, <font color='plum'><b>residues with both pathogenic and benign mutations are shown in plum</b></font>.
+
<scene name='75/752201/Cv/6'>Pathogenic and benign mutations in BRCT domain</scene>. <font color='magenta'><b>Pathogenic mutations are shown in magenta</b></font>, <font color='lime'><b>benign mutations are shown in green</b></font>, <font color='plum'><b>residues with both pathogenic and benign mutations are shown in plum</b></font>.
==Pathogenic mutations==
==Pathogenic mutations==

Revision as of 10:48, 14 February 2017

Drag the structure with the mouse to rotate

References

  1. Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat Struct Mol Biol. 2004 Jun;11(6):512-8. Epub 2004 May 9. PMID:15133502 doi:10.1038/nsmb775
  2. Williams RS, Glover JN. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. J Biol Chem. 2003 Jan 24;278(4):2630-5. Epub 2002 Nov 8. PMID:12427738 doi:10.1074/jbc.M210019200

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Joel L. Sussman

Personal tools